Go back

Lawyers and funders developing patent advice for regenerative medicine

Funders, industry groups and lawyers are said to be working on new guidance for regenerative medicine researchers to explain how to make the best us of the patent system. Sean Dennehey, the acting chief executive of the Intellectual Property Office, has said his organisation might also get involved in preparing the document.

Speaking at a hearing for a House of Lords inquiry into regenerative medicine on 27 November, patent attorney Alex Denoon said: “We’ve made a suggestion to George Freeman [the government’s life sciences adviser] and worked with a number of other players to see whether it might be possible to prepare a brief note explaining…ways in which you might be able to protect your investment…There are different business models here.”

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.